BioCentury
ARTICLE | Clinical News

Aramchol arachidyl amino cholanoic acid: Phase IIb started

March 16, 2015 7:00 AM UTC

Galmed began the double-blind, placebo-controlled, dose-ranging, international Phase IIb ARREST trial to evaluate 400 and 600 mg oral Aramchol once daily for 52 weeks in about 240 overweight or obese ...